Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
OUTLOOK THERAPEUTICS INC
OTLKCurrent price
1.57 USD
+0.07 USD (+4.67%)
Last closed
1.48 USD
Company
www.outlooktherapeutics.com
ISIN
US69012T2069
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
33 827 508 USD
Yield for 12 month
-80.95 %
1Y
3Y
5Y
10Y
15Y
OTLK
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with BioLexis Pte. Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey. Address: Building F, Iselin, NJ, United States, 08852
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
24.80 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-44 188 USD
Last Year
-204 694 USD
Current Quarter
-28 672 USD
Last Quarter
-28 195 USD
Key Figures OTLK
1 year
3 years
5 years
10 years
EBITDA
-61 188 524 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-83.69 %
PEG Ratio
–
Return On Equity TTM
-3.65 %
Wall Street Target Price
24.80 USD
Revenue TTM
5 853 537 USD
Book Value
-3.58 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
658.30 %
Dividend Yield
–
Gross Profit TTM
-42 330 856 USD
Earnings per share
-5.89 USD
Diluted Eps TTM
-5.89 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics OTLK
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History OTLK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
14.03.2024
Stock Valuation OTLK
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
2.85
Enterprise Value Revenue
26.10
Price Sales TTM
13.27
Enterprise Value EBITDA
-4.13
Price Book MRQ
10.19
Financials OTLK
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OTLK
For 52 weeks
0.87 USD
12.85 USD
50 Day MA
4.60 USD
Shares Short Prior Month
3 398 949
200 Day MA
6.90 USD
Short Ratio
1.26
Shares Short
4 132 323
Short Percent
25.71 %
BeatStart